{"id":55072,"date":"2016-12-28T16:06:00","date_gmt":"2016-12-28T20:06:00","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?p=55072"},"modified":"2022-12-01T10:59:27","modified_gmt":"2022-12-01T15:59:27","slug":"cdc-announces-increases-in-drug-and-opioidinvolved-overdose-deaths","status":"publish","type":"post","link":"https:\/\/www.nationaldrugscreening.com\/blogs\/cdc-announces-increases-in-drug-and-opioidinvolved-overdose-deaths\/","title":{"rendered":"CDC announces Increases in Drug and Opioid-Involved Overdose Deaths"},"content":{"rendered":"\n
December 16, 2016: The U.S. opioid epidemic<\/a><\/strong> is continuing. Drug overdose deaths nearly tripled during 1999\u20132014. In 2014, among 47,055 drug overdose deaths, 61% involved an opioid. During 2013\u20132014, deaths associated with the most commonly prescribed opioids (natural\/semisynthetic opioids) continued to increase slightly; however, the rapid increase in deaths appears to be driven by heroin and synthetic opioids other than methadone.<\/p>\n\n\n\n From 2014 to 2015, the death rate from synthetic opioids other than methadone, which includes fentanyl, increased by 72.2%, and heroin death rates increased by 20.6%. Rates of death involving heroin and synthetic opioids other than methadone increased across all demographic groups, regions, and in numerous states. Natural\/semi-synthetic opioid death rates increased by 2.6%, whereas, methadone death rates decreased by 9.1%. CLICK HERE TO READ MORE IN THE CDC RELEASE<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" December 16, 2016: The U.S. opioid epidemic is continuing. Drug overdose deaths nearly tripled during 1999\u20132014. In 2014, among 47,055 drug overdose deaths, 61% involved an opioid. During 2013\u20132014, deaths associated with the most commonly prescribed opioids (natural\/semisynthetic opioids) continued to increase slightly; however, the rapid increase in deaths appears to be driven by heroin […]<\/p>\n","protected":false},"author":12,"featured_media":938,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"50885,51328,51352,50949,51371,51313","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/55072"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=55072"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/55072\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/938"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=55072"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=55072"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=55072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}